Skyrizi topical and Vyleesi

• Generic Name: risankizumab
• Dosage Forms: n.a.
• Other Brand Names: Skyrizi

Risankizumab-rzaa is an interleukin-23 antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

• Generic Name: bremelanotide
• Dosage Forms: subcutaneous injection
• Other Brand Names: Vyleesi

Vyleesi (bremelanotide) is used to treat low sexual desire in women who have not gone through menopause and have not had low sexual desire in the past.

Vyleesi should be used only to treat low sexual desire that occurs with any type of sexual activity, in any sexual situation, or with any sexual partner.

Vyleesi should not be used to treat low sexual desire that is caused by relationship problems, health problems, mental illness, or by using certain drugs or medications.

Vyleesi is not for use in men, or in women who have gone through menopause. Bremelanotide should not be used to improve sexual performance.